Ramzi Hassouneh
Overview
Explore the profile of Ramzi Hassouneh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hassouneh R, Beran A, Rosenheck M, Sosio J, Olchawa N, Kubal C, et al.
J Gastrointest Surg
. 2024 Aug;
28(11):1870-1882.
PMID: 39209561
Background: Liver transplantation is the only curative treatment of end-stage liver disease. Unfortunately, a significant number of patients on the organ waitlist die waiting for an organ. Living-donor liver transplantation...
2.
Hassouneh R, Morton M, Dilly C
Clin Gastroenterol Hepatol
. 2024 Jul;
23(2):A23-A24.
PMID: 39067556
No abstract available.
3.
Hassouneh R, Flynn S, Shen S, Tseng M, Tuan Bui A, Pham J, et al.
Transplantation
. 2023 Jul;
108(1):235-241.
PMID: 37439776
Background: Loss of skeletal muscle can be accompanied by an increase in adipose tissue leading to sarcopenic obesity. There are limited data on how liver transplantation (LT) might impact adipose...
4.
Beran A, Mhanna A, Mhanna M, Hassouneh R, Abuhelwa Z, Mohamed M, et al.
Proc (Bayl Univ Med Cent)
. 2023 Mar;
36(2):151-156.
PMID: 36876272
SARS-CoV-2 vaccinations were found to be highly effective in phase 3 clinical trials. However, these trials have not reported data regarding the subgroup of liver disease or excluded patients with...
5.
Siddiqui M, Bui A, Syed T, Tseng M, Hassouneh R, Bhati C
Clin Gastroenterol Hepatol
. 2022 Feb;
21(4):1100-1102.e2.
PMID: 35181567
Hepatic fibrosis is a strong predictor of clinical outcomes following liver transplantation (LT). Despite the centrality of hepatic fibrosis in clinical outcomes, the published literature with noninvasive fibrosis assessment in...
6.
Saraireh H, Abdelfattah T, Hassouneh R, Lippman R, Puri P, Mutha P, et al.
Dig Dis Sci
. 2022 Feb;
67(11):5256-5261.
PMID: 35169957
Background: Endoscopic ultrasound-guided liver biopsy (EUS-LB) has emerged as a viable mean to obtain core tissue, but the optimal tools and techniques are still an area of active investigation. Aims:...
7.
Hassouneh R, Patel S, Shen S, Bui A, Syed T, Flynn S, et al.
Liver Transpl
. 2022 Feb;
28(7):1186-1195.
PMID: 35124881
Cardiovascular disease (CVD) is an important cause of mortality among liver transplantation (LT) recipients; however, the data on CVD risk stratification following LT are limited. Thus, the primary aim of...
8.
Hassouneh R, Shen S, Lee O, Hart R, Rhea L, Fadden P
J Hematol
. 2021 Sep;
10(4):202-205.
PMID: 34527117
Most individuals with vitamin B12 deficiency present with anemia, fatigue, and neurologic disturbances such as paresthesia and loss of sensory function if chronic. However, in severe states, it may manifest...
9.
Acharya C, Nadhem O, Shaw J, Hassouneh R, Fagan A, McGeorge S, et al.
Am J Gastroenterol
. 2021 Jun;
116(12):2385-2389.
PMID: 34140445
Introduction: We aimed to determine the effect of comorbidities on covert hepatic encephalopathy (CHE) diagnosis and overt hepatic encephalopathy (OHE) development. Methods: Cirrhotic outpatients underwent CHE testing and 2-year follow-up....
10.
Duong N, Reuter B, Saraireh H, Nadhem O, Acharya C, Fagan A, et al.
Clin Gastroenterol Hepatol
. 2021 May;
20(4):e897-e901.
PMID: 33991690
The spectrum of hepatic encephalopathy (HE) ranges from overt HE (OHE) to cognitive impairment (ie, covert) HE (CHE). The first-line therapy is lactulose, which is titrated to achieve ~2-3 soft/loose...